Ministry of Health and Population, Malawi
11
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
9.1%
1 terminated/withdrawn out of 11 trials
87.5%
+1.0% vs industry average
27%
3 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
Role: collaborator
CPAP Improving Mortality for Pneumonia in African Children Trial
Role: collaborator
Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in Malawi
Role: collaborator
Engaging Informal Health Care Providers on Case Detection and Treatment Initiation Rates for TB and HIV in Rural Malawi (Triage Plus)
Role: collaborator
Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi
Role: collaborator
Promoting Uptake and Retention of Option B+ in Malawi
Role: collaborator
Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi
Role: collaborator
Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi
Role: collaborator
A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi
Role: collaborator
Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)
Role: collaborator
Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi
Role: collaborator
All 11 trials loaded